Registered cervical samples
353,435
HPV and/or cytology samples registered in 2025, including screening, symptoms and follow-up.
Original source from FHIFHI · Official statistics
Cervical screening in Norway
How many people participate in Norway's Cervical Screening Programme? Explore trends over time, differences between age groups and the available breakdowns by county.
2025 · All of Norway · FHI
Participation in the Norwegian Cervical Screening Programme
72.7 %
Proportion of women aged 25–69 who participated within the programme's recommended interval in 2025.
Source: FHI, annual report 2025Share of registered samples that were screening samples
65 %
Share of all registered cervical samples that were screening samples, rounded as reported by FHI.
Original source from FHINew cases of cervical cancer
259
New cervical cancer cases registered in Norway in 2025. This is cancer incidence, not the number of positive screening tests.
Original source from FHIDeaths from cervical cancer
64
Deaths attributed to cervical cancer registered in Norway in 2025. These deaths do not necessarily concern people diagnosed in 2025.
Original source from FHICoverage targets and differences between measures
FHI has a target coverage rate above 80 %. Coverage and participation within the recommended screening interval can have different definitions. We therefore do not automatically present the difference between this target and the 72.7 % participation figure as a shortfall from the target.
Numbers of samples, new cancer cases and deaths also describe different measures. They cannot be used directly to calculate how many screening samples prevented cancer.
Read FHI's annual reportFHI · Indikator 25 · 1994–2024
Participation in cervical screening over time
The proportion in different age groups who participated within the recommended screening interval. We reproduce FHI's published table with whole percentages. These are not counts of samples taken in each individual calendar year.
2024: 72 % · ages 25–69
The chart includes its original source, unit of measurement, caveats and Womanhood Initiative credit. Missing values are not treated as zero.
Show exact annual values in a table
| Year | ages 25–69 | ages 25–33 | ages 34–54 | ages 55–69 |
|---|---|---|---|---|
| 2024 | 72 % | 67 % | 75 % | 70 % |
| 2023 | 73 % | 70 % | 76 % | 70 % |
| 2022 | 72 % | 70 % | 75 % | 70 % |
| 2021 | 72 % | 70 % | 74 % | 69 % |
| 2020 | 71 % | 68 % | 73 % | 69 % |
| 2019 | 72 % | 69 % | 74 % | 70 % |
| 2018 | 72 % | 70 % | 74 % | 70 % |
| 2017 | 71 % | 69 % | 73 % | 69 % |
| 2016 | 70 % | 66 % | 72 % | 68 % |
| 2015 | 69 % | 65 % | 72 % | 68 % |
| 2014 | 68 % | 63 % | 71 % | 68 % |
| 2013 | 69 % | 63 % | 71 % | 68 % |
| 2012 | 69 % | 63 % | 72 % | 69 % |
| 2011 | 71 % | 65 % | 73 % | 70 % |
| 2010 | 71 % | 66 % | 74 % | 70 % |
| 2009 | 72 % | 68 % | 75 % | 71 % |
| 2008 | 73 % | 70 % | 76 % | 71 % |
| 2007 | 74 % | 72 % | 76 % | 72 % |
| 2006 | 75 % | 73 % | 77 % | 72 % |
| 2005 | 76 % | 75 % | 78 % | 73 % |
| 2004 | 77 % | 77 % | 79 % | 74 % |
| 2003 | 77 % | 77 % | 79 % | 73 % |
| 2002 | 77 % | 78 % | 78 % | 71 % |
| 2001 | 75 % | 78 % | 77 % | 68 % |
| 2000 | 75 % | 79 % | 77 % | 67 % |
| 1999 | 76 % | 81 % | 78 % | 67 % |
| 1998 | 75 % | 81 % | 78 % | 65 % |
| 1997 | 75 % | 82 % | 77 % | 61 % |
| 1996 | 74 % | 83 % | 77 % | 58 % |
| 1995 | 72 % | 83 % | 76 % | 53 % |
| 1994 | 68 % | 81 % | 72 % | 47 % |
The values in FHI's table are rounded to whole percentages. The 2025 figure was published separately at 72.7% for the entire target population, so it is not included as a rounded estimate in the historical table. 'Participation within the recommended screening interval' and 'five-year coverage' are different measures.
FHI · Norwegian Cervical Screening Programme · annual report 2025
Cervical samples by age
What proportion of women in each age group had at least one registered cervical sample during the five-year period 2021–2025? We show the age groups covered by the Norwegian Cervical Screening Programme, ages 25–69.
25–29 years67.6 %
30–34 years78.8 %
35–39 years83.7 %
40–44 years80.2 %
45–49 years77.3 %
50–54 years76.6 %
55–59 years76.7 %
60–64 years73.9 %
65–69 years69.7 %
Common scale: 0–100 percent. The bars show the proportion of women in each age group over five years, not the proportion tested in 2025 alone.
See exact annual-report figures in a table
| Age | Proportion |
|---|---|
| 25–29 years | 67.6 % |
| 30–34 years | 78.8 % |
| 35–39 years | 83.7 % |
| 40–44 years | 80.2 % |
| 45–49 years | 77.3 % |
| 50–54 years | 76.6 % |
| 55–59 years | 76.7 % |
| 60–64 years | 73.9 % |
| 65–69 years | 69.7 % |
Important: This is five-year coverage for different age groups, not FHI's 'participation within the recommended screening interval' indicator of 72.7 percent. Nor should the figures be interpreted as meaning a screening sample was always required throughout the five-year period. The screening method and recommended intervals have changed.
Source: FHI, Norwegian Cervical Screening Programme annual report 2025, Table 3.4. The report describes changes in HPV screening and coverage calculations. Original figures checked on 3 November 2026.
Open the original FHI report and Table 3.4Historical county data · FHI · 2016–2020
Coverage by county
Select a county and measure to explore trends in FHI's published coverage data. The nationwide line provides a comparison. The measures use different age groups and time intervals and must not be treated as the same indicator.
Oslo: 68.1 % in 2020 · All of Norway: 68.2 %
OsloAll of Norway
Show all annual values for the selected county
| Year | Oslo | All of Norway |
|---|---|---|
| 2016 | 67.1 % | 66.9 % |
| 2017 | 68.7 % | 69.4 % |
| 2018 | 68.6 % | 69.9 % |
| 2019 | 67.7 % | 69.3 % |
| 2020 | 68.1 % | 68.2 % |
Show all counties in 2020
| County | 3.5-year coverage, ages 25–33 |
|---|---|
| Innlandet | 70.6 % |
| Agder | 70.2 % |
| Nordland | 69.8 % |
| Troms og Finnmark | 69.3 % |
| Oslo | 68.1 % |
| Vestfold | 67.1 % |
| Møre og Romsdal | 66.2 % |
| Viken | 65.7 % |
| Rogaland | Not reported |
| Trøndelag | Not reported |
| Vestland | Not reported |
| All of Norway | 68.2 % |
Missing source values are labelled 'Not reported' and displayed as gaps in the chart. The printed report title refers to 2017–2021, but the column headings in the published table refer to 2016–2020. We follow the column headings; this discrepancy requires clarification with the source. County names and boundaries are historical and are not directly comparable with the county structure in 2025.
Original source: Norwegian Cancer Registry, Cervical Screening Programme annual report 2021, Appendix C, Table C.1, page 40Explore cervical health
Statistics show how the screening programme is developing. Explore the research and understand HPV test results.
County-level participation in 2025
FHI reports participation by county and age group in Figure 3.5 of its 2025 annual report. We do not yet have the exact table values for this figure and therefore do not publish estimated county percentages. The historical charts above cover different measures and an earlier county structure.
View FHI's county chart for 2025How does Tidlignok use these figures?
The figures are produced and published by FHI. We reproduce the original values, years and definitions and make them easier to explore. We do not carry out a new scientific approval of official statistics. We verify that our presentation accurately reflects the source.